Maurice Perol

Maurice Perol

UNVERIFIED PROFILE

Are you Maurice Perol?   Register this Author

Register author
Maurice Perol

Maurice Perol

Publications by authors named "Maurice Perol"

Are you Maurice Perol?   Register this Author

77Publications

3085Reads

20Profile Views

Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer.

Lung Cancer 2019 May 2;131:6-13. Epub 2019 Mar 2.

David Geffen School of Medicine at UCLA/Translational Research in Oncology-US Network, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.03.001DOI Listing
May 2019

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2017 08 6;377(9):829-838. Epub 2017 Jun 6.

From Lausanne University Hospital, Lausanne (S.P.), and F. Hoffmann-La Roche, Basel (A.Z., E.M., S. Golding, B.B., J.N.) - both in Switzerland; University of Colorado, Denver (D.R.C.); Massachusetts General Hospital, Boston (A.T.S.); University of Michigan, Ann Arbor (S. Gadgeel); Samsung Medical Center, Sungkyunkwan University School of Medicine (J.S.A.), and Seoul National University Hospital (D.-W.K.) - both in Seoul, South Korea; Chao Family Comprehensive Cancer Center, University of California, Irvine, School of Medicine, Orange (S.-H.I.O.); Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France (M.P.); Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland (R.D.); Catalan Institute of Oncology, Barcelona (R.R.); Roche Innovation Center, New York (P.N.M.); and State Key Laboratory of South China, Chinese University of Hong Kong, Hong Kong (T.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1704795DOI Listing
August 2017

Alectinib for treatment of ALK-positive non-small-cell lung cancer.

Future Oncol 2017 Feb 26;13(4):321-335. Epub 2016 Oct 26.

Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0386DOI Listing
February 2017

The safety and efficacy of ramucirumab in combination with docetaxel in the treatment of lung cancer.

Expert Rev Anticancer Ther 2016 Nov 8;16(11):1119-1129. Epub 2016 Oct 8.

a Department of Medical Oncology , Léon Bérard Cancer Center , Lyon , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2016.1241147DOI Listing
November 2016

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

J Clin Oncol 2016 May 16;34(13):1476-83. Epub 2016 Feb 16.

Romain Corre and Hervé Léna, Centre Hospitalier Universitaire de Rennes, Rennes; Laurent Greillier, Université de Médecine, Marseille; Hervé Le Caër, Centre Hospitalier de Draguignan, Draguignan; Clarisse Audigier-Valette, Centre Hospitalier Intercommunal de Toulon; Henri Bérard, Hôpital Inter Armées Sainte-Anne, Toulon; Nathalie Baize, Centre Hospitalier Universitaire d'Angers, Angers; Lionel Falchero, Centre Hospitalier de Villefranche sur Saône, Villefranche sur Saône; Isabelle Monnet and Christos Chouaïd, Centre Hospitalier Intercommunal de Créteil, Créteil; Eric Dansin, Centre Oscar Lambret, Lille; Alain Vergnenègre, Centre Hospitalier Universitaire du Cluzeau, Limoges; Marie Marcq, Centre Hospitalier Départemental les Oudairies, La Roche-sur-Yon; Chantal Decroisette, Centre Hospitalier d'Annecy, Annecy; Jean-Bernard Auliac, Centre Hospitalier de Mantes La Jolie, Mantes la Jolie; Suzanna Bota, Centre Hospitalier Universitaire Charles Nicolle, Rouen; Régine Lamy, Centre Hospitalier de Bretagne Sud, Lorient; Cécile Dujon, Hôpital A. Mignot, Le Chesnay; Maurice Pérol, Centre Léon Bérard, Lyon; Jean-Pierre Daurès and Carine Plassot, Université Montpellier 1, Montpellier; Renaud Descourt, Centre Hospitalier Universitaire de Brest, Brest, France; and Bartomeu Massuti, Hospital General Universitario de Alicante, Alicante, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.5839DOI Listing
May 2016

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.

Eur Respir J 2015 Dec 22;46(6):1773-80. Epub 2015 Oct 22.

Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, France EMR 3738 "Therapeutic Targeting in Oncology", Lyon Sud - Charles Mérieux Faculty of Medicine, Lyon 1 University, Oullins, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00676-2015DOI Listing
December 2015

Negative results of METLung study: an opportunity to better understand the role of MET pathway in advanced NSCLC.

Authors:
Maurice Pérol

Transl Lung Cancer Res 2014 Dec;3(6):392-4

Department of Medical Oncology, Léon Bérard Cancer Center, 69008 Lyon, France.

View Article

Download full-text PDF

Source
http://www.tlcr.org/article/view/3130/4021
Publisher Site
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.09.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367676PMC
December 2014

The TAILOR study: to agree or to disagree?

Lung Cancer 2014 Jun 26;84(3):315-6. Epub 2014 Mar 26.

Medical Cancerology Department, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.03.019DOI Listing
June 2014

Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).

Lung Cancer 2014 Feb 21;83(2):182-8. Epub 2013 Dec 21.

Université Grenoble 1, INSERM, U 823, Institut A Bonniot, Université J Fourier, Rond-point de la Chantourne, 38706 La Tronche Cedex, France; Department of Pathology, Teaching Hospital A Michallon, BP217, 38043 Grenoble Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.12.003DOI Listing
February 2014

[Identification of occupational exposures among patients with lung cancer].

Bull Cancer 2013 Jul-Aug;100(7-8):661-70

Centre Léon-Bérard, Unité Cancer et Environnement, 28 rue Laënnec, 69373 Lyon cedex 08, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2013.1783DOI Listing
September 2013

Reply to N. Singh et al.

J Clin Oncol 2013 Mar;31(9):1251-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.8248DOI Listing
March 2013

Diffuse interstitial lung disease linked to vandetanib.

Clin Lung Cancer 2012 May 1;13(3):236-8. Epub 2011 Dec 1.

Pulmonology, Croix Rousse Hospital, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.10.004DOI Listing
May 2012

Are clinical guidelines applied in routine daily practice?: a French regional survey of physicians' clinical practices in lung cancer management (EPOTRA).

Clin Lung Cancer 2011 Sep 14;12(5):298-306. Epub 2011 Jul 14.

Service de pneumologie et d'oncologie thoracique, CH Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.04.003DOI Listing
September 2011

Professional practice and accessibility to equipment in thoracic oncology. Results of a survey in Rhônes-Alpes region (France).

Bull Cancer 2011 Jun 9. Epub 2011 Jun 9.

Centre hospitalier Lyon-Sud, Hospices civils de Lyon, service de pneumologie et d'oncologie thoracique, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite Cedex, FranceCentre hospitalier Lyon-Sud, Hospices civils de Lyon, service de pneumologie et d'oncologie thoracique, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite Cedex, FranceCentre hospitalier Lyon-Sud, Hospices civils de Lyon, service de pneumologie et d'oncologie thoracique, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite Cedex, France.

View Article

Download full-text PDF

Source
http://www.john-libbey-eurotext.fr/medline.md?doi=10.1684/bd
Publisher Site
http://dx.doi.org/10.1684/bdc.2011.1366DOI Listing
June 2011

[Maintenance therapy in advanced non-small cell lung cancer: A new paradigm?].

Presse Med 2011 Apr 23;40(4 Pt 1):404-14. Epub 2011 Feb 23.

Centre Léon-Bérard, département de médecine, 69373 Lyon cedex 08, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07554982110006
Publisher Site
http://dx.doi.org/10.1016/j.lpm.2011.01.009DOI Listing
April 2011

The role of pemetrexed in lung adenocarcinoma, mixed subtype with bronchioloalveolar carcinoma features.

Curr Drug Targets 2010 Jan;11(1):74-7

Hôpital de la Croix Rousse, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138945010790031045DOI Listing
January 2010

Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.

Lung Cancer 2009 Sep 5;65(3):385-7. Epub 2009 Apr 5.

Service de Pneumologie, Unité d'Oncologie Thoracique, Hôpital de la Croix Rousse, Lyon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2009.02.018DOI Listing
September 2009

[Angiogenesis and lung cancer].

Bull Cancer 2007 Jul;94 Spec No:S220-31

Service de Pneumologie, Hôpital de la Croix-Rousse, 69317 Lyon Cedex 04.

View Article

Download full-text PDF

Source
July 2007

[Clinical results observed with tyrosine kinase inhibitors].

Authors:
Maurice Pérol

Rev Pneumol Clin 2007 Jan;63(1 Pt 2):2S7-9

Hôpital de la Croix-Rousse, Service de pneumologie, 93, Grande Rue de la Croix-Rousse, 69317 Lyon Cedex 4.

View Article

Download full-text PDF

Source
January 2007

Paclitaxel hypersensitivity reactions: assessment of the utility of a test-dose program.

Cancer J 2006 May-Jun;12(3):237-45

Pharmacy Department, Croix-Rousse Hospital, Lyon, France.

View Article

Download full-text PDF

Source
October 2006

Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.

Clin Cancer Res 2005 Oct;11(19 Pt 1):6862-7

Department of Immunology, University Hospital Center, Saint Etienne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-0043DOI Listing
October 2005

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

Lung Cancer 2005 Sep;49(3):363-70

Service de Médecine Interne, Hôtel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2005.04.008DOI Listing
September 2005

Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

Bull Cancer 2005 Feb;92(2):E25-30

Inserm U453, Service d'hématologie, Centre hospitalier Lyon-Sud, 69495 Pierre-Bénite Cedex.

View Article

Download full-text PDF

Source
February 2005

Percutaneous radiofrequency ablation of a lung metastasis: delayed cavitation with no infection.

J Comput Assist Tomogr 2002 Nov-Dec;26(6):1032-4

Department of Radiology, Hôpital de la Croix-Rousse, 103 grande rue de la Croix-Rousse, 69317 Lyon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004728-200211000-00031DOI Listing
January 2003